OBJECTIVES: Using a rabbit model of post-traumatic joint contractures, we investigated whether treatment with a mast cell stabilizer after joint injury would lessen the molecular manifestations of joint capsule fibrosis. METHODS: Surgical joint injury was used to create stable post-traumatic contractures of the knee in skeletally mature New Zealand white rabbits. Four groups of animals were studied: a non-operated control group (n = 8), an operated contracture group (n = 13) and two operated groups treated with the mast cell stabilizer, ketotifen, at doses of 0.5 mg/kg (n = 9) and 1.0 mg/kg (n = 9) twice daily. Joint capsule fibrosis was assessed by quantifying the mRNA and protein levels of α-SMA, tryptase, TGF-β1, collagen I and collagen III. Significance was tested using an ANOVA analysis of variance. RESULTS: The protein and mRNA levels of α-SMA, TGF-β1, tryptase and collagen I and III were significantly elevated in the operated contracture group compared to control (p < 0.01). In both ketotifen-treated groups, protein and mRNA levels of α-SMA, TGF-β1 and collagen I were significantly reduced compared to the operated contracture group (p < 0.01). CONCLUSIONS: These data suggest an inflammatory pathway mediated by mast cell activation is involved in joint capsule fibrosis after traumatic injury.
OBJECTIVES: Using a rabbit model of post-traumatic joint contractures, we investigated whether treatment with a mast cell stabilizer after joint injury would lessen the molecular manifestations of joint capsule fibrosis. METHODS: Surgical joint injury was used to create stable post-traumatic contractures of the knee in skeletally mature New Zealand white rabbits. Four groups of animals were studied: a non-operated control group (n = 8), an operated contracture group (n = 13) and two operated groups treated with the mast cell stabilizer, ketotifen, at doses of 0.5 mg/kg (n = 9) and 1.0 mg/kg (n = 9) twice daily. Joint capsule fibrosis was assessed by quantifying the mRNA and protein levels of α-SMA, tryptase, TGF-β1, collagen I and collagen III. Significance was tested using an ANOVA analysis of variance. RESULTS: The protein and mRNA levels of α-SMA, TGF-β1, tryptase and collagen I and III were significantly elevated in the operated contracture group compared to control (p < 0.01). In both ketotifen-treated groups, protein and mRNA levels of α-SMA, TGF-β1 and collagen I were significantly reduced compared to the operated contracture group (p < 0.01). CONCLUSIONS: These data suggest an inflammatory pathway mediated by mast cell activation is involved in joint capsule fibrosis after traumatic injury.
Authors: Kevin A Hildebrand; Mei Zhang; Wistara van Snellenberg; Graham J W King; David A Hart Journal: Clin Orthop Relat Res Date: 2004-02 Impact factor: 4.176
Authors: Afton K Limberg; Meagan E Tibbo; Christopher G Salib; Alex R McLaury; Travis W Turner; Charlotte E Berry; Anthony G Jay; Jodi M Carter; Brad Bolon; Daniel J Berry; Mark E Morrey; Joaquin Sanchez-Sotelo; Andre J van Wijnen; Matthew P Abdel Journal: J Orthop Res Date: 2020-03-11 Impact factor: 3.494
Authors: Sarah F Giardina; Douglas S Werner; Maneesh Pingle; Donald E Bergstrom; Lee D Arnold; Francis Barany Journal: Pharmacology Date: 2018-08-22 Impact factor: 2.547
Authors: Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand Journal: Adv Wound Care (New Rochelle) Date: 2015-03-01 Impact factor: 4.730
Authors: Michael R Convente; Haitao Wang; Robert J Pignolo; Frederick S Kaplan; Eileen M Shore Journal: Curr Osteoporos Rep Date: 2015-04 Impact factor: 5.096
Authors: Franz Xaver Koeck; Miriam Schmitt; Clemens Baier; Hubert Stangl; Johannes Beckmann; Joachim Grifka; Rainer H Straub Journal: J Orthop Surg Res Date: 2016-02-17 Impact factor: 2.359